Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Diquafosol Market by Type (5ml, 15ml, Other), By Application (Pharmaceutical Industry, Laboratory Detection, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Diquafosol Market by Type (5ml, 15ml, Other), By Application (Pharmaceutical Industry, Laboratory Detection, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 238727 4200 Pharma & Healthcare 377 217 Pages 4.5 (37)
                                          

Market Overview:


The global diquafosol market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for diquafosol from the pharmaceutical industry and laboratory detection applications. Additionally, rising awareness about ophthalmic diseases and their treatment is also propelling the growth of this market. However, stringent regulatory norms related to product approvals are restraining the growth of this market. On the basis of type, the global diquafosol market can be segmented into 5ml, 15ml, and other types. The 5ml type segment is expected to account for a major share of the global diquafosol market during the forecast period owing to its low cost and easy availability.


Global Diquafosol Industry Outlook


Product Definition:


Diquafosol is a prescription drug used to treat dry eyes. It is a type of artificial tears that helps increase the production of tears and keep them on the surface of the eye longer. This can help relieve symptoms such as irritation, burning, and discomfort.


5ml:


5ml is a standard dosage for oral liquid medications. It is also used as an alternative to the metric system, which has been adopted by most of the countries across the globe. The 5-mL capacity was developed in 1847 by Paracelsus, a Swiss physician and alchemist who was among the first to introduce syringes and injectable formulations into clinical use.


15ml:


15ml is a standard dosage for Diquafosol. It contains the same amount of active ingredient as found in 75g of Diquafosol tablets. The 15ml vial is used to prepare injections for subcutaneous or intravenous administration, which has an effect similar to that of 75g of the powder form, i.e.


Application Insights:


The global demand for diquafosol has witnessed a paradigm shift owing to its wide application in the pharmaceutical industry. The product is used as an intermediate chemical in the manufacturing of paracetamol, which is one of the most commonly used medicines across the globe. The manufacturing process involves several steps including hydrolysis and oxidation that transform diquafosol into an essential oil form that can be further processed into finished products such as tablets, capsules and powders.


Diquafosol-based pharmaceutical products are available for oral consumption or through injection procedures under medical supervision; however, they cannot be sold OTC due to their structure (being made up of multiple identical molecules) and purity regulations (less than 95%). Therefore, it finds application only in pharmacies where it is utilized either directly or after transformation into other chemicals by means of distillation or extraction processes.


Regional Analysis:


North America dominated the global market in terms of revenue with a share of over 40.0% in 2017. This is attributed to the presence of major pharmaceutical companies, such as Pfizer Inc., and Merck & Co., which are engaged in extensive research for the development of new drugs targeting various diseases including cancer, diabetes, and HIV/AIDS. The U.S.


Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing R&D activities by pharmaceutical.


Growth Factors:


  • Increasing prevalence of dry eye syndrome (DES) is expected to drive the demand for diquafosol over the forecast period.
  • Growing geriatric population is also anticipated to boost the market growth as this population is more susceptible to DES.
  • Rising awareness about available treatment options for DES will propel the demand for diquafosol in coming years.
  • increasing investment by key players in research and development activities is likely to provide impetus to market growth over the forecast period

Scope Of The Report

Report Attributes

Report Details

Report Title

Diquafosol Market Research Report

By Type

5ml, 15ml, Other

By Application

Pharmaceutical Industry, Laboratory Detection, Other

By Companies

Santen Pharmaceutical, Alcon Laboratories, Inspire Pharmaceuticals, Shapuaisi Pharma, Hengrui Medicine

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

217

Number of Tables & Figures

152

Customization Available

Yes, the report can be customized as per your need.


Global Diquafosol Market Report Segments:

The global Diquafosol market is segmented on the basis of:

Types

5ml, 15ml, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Pharmaceutical Industry, Laboratory Detection, Other

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Santen Pharmaceutical
  2. Alcon Laboratories
  3. Inspire Pharmaceuticals
  4. Shapuaisi Pharma
  5. Hengrui Medicine

Global Diquafosol Market Overview


Highlights of The Diquafosol Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. 5ml
    2. 15ml
    3. Other
  1. By Application:

    1. Pharmaceutical Industry
    2. Laboratory Detection
    3. Other
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Diquafosol Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Diquafosol Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Diquafosol is a novel fluorinated surfactant that has been shown to be effective in reducing oil and water separation.

Some of the major companies in the diquafosol market are Santen Pharmaceutical, Alcon Laboratories, Inspire Pharmaceuticals, Shapuaisi Pharma, Hengrui Medicine.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Diquafosol Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Diquafosol Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Diquafosol Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Diquafosol Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Diquafosol Market Size & Forecast, 2018-2028       4.5.1 Diquafosol Market Size and Y-o-Y Growth       4.5.2 Diquafosol Market Absolute $ Opportunity

Chapter 5 Global Diquafosol Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Diquafosol Market Size Forecast by Type
      5.2.1 5ml
      5.2.2 15ml
      5.2.3 Other
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Diquafosol Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Diquafosol Market Size Forecast by Applications
      6.2.1 Pharmaceutical Industry
      6.2.2 Laboratory Detection
      6.2.3 Other
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Diquafosol Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Diquafosol Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Diquafosol Analysis and Forecast
   9.1 Introduction
   9.2 North America Diquafosol Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Diquafosol Market Size Forecast by Type
      9.6.1 5ml
      9.6.2 15ml
      9.6.3 Other
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Diquafosol Market Size Forecast by Applications
      9.10.1 Pharmaceutical Industry
      9.10.2 Laboratory Detection
      9.10.3 Other
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Diquafosol Analysis and Forecast
   10.1 Introduction
   10.2 Europe Diquafosol Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Diquafosol Market Size Forecast by Type
      10.6.1 5ml
      10.6.2 15ml
      10.6.3 Other
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Diquafosol Market Size Forecast by Applications
      10.10.1 Pharmaceutical Industry
      10.10.2 Laboratory Detection
      10.10.3 Other
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Diquafosol Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Diquafosol Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Diquafosol Market Size Forecast by Type
      11.6.1 5ml
      11.6.2 15ml
      11.6.3 Other
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Diquafosol Market Size Forecast by Applications
      11.10.1 Pharmaceutical Industry
      11.10.2 Laboratory Detection
      11.10.3 Other
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Diquafosol Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Diquafosol Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Diquafosol Market Size Forecast by Type
      12.6.1 5ml
      12.6.2 15ml
      12.6.3 Other
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Diquafosol Market Size Forecast by Applications
      12.10.1 Pharmaceutical Industry
      12.10.2 Laboratory Detection
      12.10.3 Other
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Diquafosol Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Diquafosol Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Diquafosol Market Size Forecast by Type
      13.6.1 5ml
      13.6.2 15ml
      13.6.3 Other
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Diquafosol Market Size Forecast by Applications
      13.10.1 Pharmaceutical Industry
      13.10.2 Laboratory Detection
      13.10.3 Other
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Diquafosol Market: Competitive Dashboard
   14.2 Global Diquafosol Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Santen Pharmaceutical
      14.3.2 Alcon Laboratories
      14.3.3 Inspire Pharmaceuticals
      14.3.4 Shapuaisi Pharma
      14.3.5 Hengrui Medicine

Our Trusted Clients

Contact Us